DanielAMulrooneyMD
Pediatric Hematology & Oncology • Memphis, TNAssistant Professor, Pediatrics, University of Minnesota Medical School
Are you Dr. Mulrooney?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 54 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 888-226-4343
Summary
- Dr. Daniel Mulrooney, MD is a pediatric hematologist/oncologist in Memphis, Tennessee. He is currently licensed to practice medicine in Tennessee and Minnesota. He is affiliated with St. Jude Children's Research Hospital and is an Assistant Professor at University of Minnesota Medical School.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2001 - 2004- University of MinnesotaResidency, Internal Medicine/Pediatrics, 1997 - 2001
Loyola University Chicago Stritch School of MedicineClass of 1997
Certifications & Licensure
MN State Medical License 2004 - 2025
TN State Medical License 2012 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
- Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
- Vascular Assessment in Adult Survivors of Childhood Cancer Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- Kidney Function and Body Composition in Adult Survivors of Unilateral, Non-Syndromic Wilms Tumor: A Report From the St. Jude Lifetime Cohort Study.Daniel M Green, Kendrick Li, Sue C Kaste, Kirsten K Ness, Matthew J Krasin
Pediatric Blood & Cancer. 2025-03-01 - Attributable Risk and Consequences of Bone Mineral Density Deficits in Childhood Cancer Survivors.Chelsea G Goodenough, Jessica L Baedke, Angela M Delaney, Carmen L Wilson, Tara M Brinkman
JAMA Network Open. 2025-01-02 - 1 citationsSerum Proteins Predict Treatment-Related Cardiomyopathy Among Survivors of Childhood Cancer.Suresh Poudel, Him Shrestha, Yue Pan, Qian Li, Kendrick Li
JACC. Cardiooncology. 2025-01-01
Authored Content
- Association of Hearing Impairment with Neurocognition in Survivors of Childhood CancerJuly 2020
Press Mentions
Adult Survivors of Childhood Cancer Are Experiencing Fewer Major Cardiac EventsJanuary 21st, 2020
Childhood Cancer Tx Less Cardiotoxic, but Heart Risks PersistJanuary 16th, 2020
Childhood Cancer Survivors Need to Be Monitored for Complications, Study SaysAugust 15th, 2016- Join now to see all
